RSS

Aptar Pharma

Drug delivery solutions provider AptarGroup has announced it has acquired Noble International, a provider of drug delivery training devices. Read more

News

Aptar Pharma has acquired two leading analytical services as part of a strategy to broaden its portfolio and help accelerate and derisk complex product developments. Read more

News

A breakthrough combination therapy to help treat depression has been approved by the FDA. Read more

News

Drug delivery systems provider Aptar Pharma has announced its preservative-free multidose Ophthalmic Squeeze Dispenser has been approved for a drug developed for to help glaucoma patients. Read more

News

Leading drug delivery systems provider Aptar Pharma has showcased its latest connected devices at Pharmapack. Read more

News

Drug delivery systems provider, Aptar Pharma, has launched its new portable respiratory device at CPhI Worldwide. Read more

News

Aptar Pharma, in combination with Schott Glass and EMA Pharmaceuticals, has announced that it will launch Aptar Pharma QuickStart for injectable drug development at CPhI Worldwide 2018, in Madrid today. Read more

News

Drug delivery systems provider, Aptar Pharma, will be launching its new portable respiratory device at CPhI worldwide, later this year. Read more

News

Not even 12 cm of snowfall could deter the hardy visitors to Pharmapack (well mostly) on day one and it certainly didn’t impact the amount of innovations from the show floor, which is expected to continue. Here is our brief round-up for day two Read more

News

Here, we feature a sneak peek preview of some of the companies that will exhibiting at this year’s CPhI event. Read more

Technology

Joachim Koerner, director e-Device, R&D Prescription Division, Aptar Pharma, discusses intranasal drug delivery and how an integrated electronic lockout device can assist with patient adherence and help prevent drug misuse. Read more

Opinion

A recent partnership to address the challenge of monitoring adherence in ophthalmic clinical trials was formed between Aptar Pharma and Kali Care. Here, Sina Fateh and Sai Shankar discuss this alliance further. Read more

, Opinion

Manufacturer of drug delivery systems for nasal applications, Aptar Pharma, has announced the installation of a new assembly machine for its Child-Resistant and Senior-Friendly Classic Nasal Pumps at the Congers site in North America. Read more

Technology

Ophthalmic Squeeze Dispenser

Courtesy of Allergan

Aptar Pharma’s innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser is now available for the first time for patients in the US prescription market using Allergan’s Restasis MultiDose 0.05%. Read more

News

Aptar-Pharma-.gif

Aptar Pharma Congers - Courtesy of Aptar Pharma

The new expansion for Aptar Pharma’s Congers site (New York, USA) was inaugurated on 20 March. Read more

News

Aptar Pharma has signed an exclusive development and license agreement with BD Becton, Dickinson and Company Read more

News

Aptar Pharma’s Prohaler is a smart DPI that has been developed with the patient in mind. This, says Aptar Pharma, makes it intuitive and simple to use by all asthma and COPD patients Read more

Technology

Aptar Pharma has obtained a State Food and Drug Administration (SFDA) import license approval to deliver its preservative-free multi-dose systems to customers in China. Read more

News

Aptar Pharma will unveil its Prohaler — the smart DPI for optimal patient compliance. Read more

News

RDD Asia 2014 seeks to link Asian regulators, industrial and academic scientists, clinicians and business professionals with their international counterparts, together working toward the goal of advancing inhaled and nasal drug therapy worldwide. Read more